9th Worldwide Network for Blood and Marrow Transplantation (WBMT) Congress in Ulaanbaatar, Mongolia
25.-28. June 2025
This represents a historical event involving global experts, who are known for their efforts to improve health care access and treatment throughout the World. This workshop is a continuation of events pioneered by WBMT, aiming at helping countries with restricted transplant resources and activity. A Nursing hybrid Workshop Program is included.
Register Now
Read about the latest news on the cooperation with the WHO at the annual 77th World Health Assembly (WHA) meeting in Geneva (May 27th to June 1st) and about the 2024 WHA 11.2 transplantation NSA constituency statement.
Read letterJoint Statement on Crisis in Ukraine
The American Society of Transplantation and Cellular Therapy (ASTCT), European Society for Blood Marrow Transplantation (EBMT), and Worldwide Network for Blood Marrow Transplantation (WBMT) firmly condemn the war started by Russian military forces in Ukraine. In particular, ASTCT, EBMT, and WBMT request that peace negotiations prioritize the needs of the most vulnerable Ukrainian people. Casualties among innocent civilians increase by the minute, including children. Patients with severe conditions, such as those with cancer or undergoing life-saving transplants, are currently affected by lack of medications and medical supplies, limited ability to travel to hospitals, lack of adequate nutrition. Healthcare providers and hospital staff in Kyiv remain in their hospitals to treat the patients in shelters, while bombs continue to hit the city.
Read the full letter here.
Stem cell transplantation underutilized for acute myeloid leukemia
Utilization of hematopoietic stem cell transplantation for acute myeloid leukemia has increased over time but remains far below optimal levels, according to study results presented at ASH Annual Meeting and Exposition.
Tokaz spoke with Healio about the study findings and their potential implications, as well as the importance of expanding use of this curative treatment for AML.
Read more and view the recording of the interview by clicking the button below.
View recordingExperts at ASH 2022 Share Global Data on Acute Myeloid Leukemia
In an interview with HCPLive, Tokaz and Force shared expert insight on their investigation and why this worldwide perspective is crucial to progression of oncology research and treatment.
“There’s a mounting global cancer crisis,” Tokaz explained. “By 2040, new cancer diagnoses are expected to double in regions dominated by low-income countries—which are the region’s least equipped to deal with this pending cancer epidemic, and by 2040, estimates are that there’ll be over 18 million deaths from cancer worldwide.”
Read more and view the recording of the interview by clicking the button below.
WBMT is involved in